Nanotechnology Conference and Trade Show - Nanotech 2006
> Program > Technical Conferences > Business & Development > Nano Impact Workshop > Nanotech Job Fair > Expo
Index of Authors
Index of Keywords
Confirmed Speakers
Conferences & Symposia

Conference Proceedings

Conference Technical Proceedings
Nanotech 2006 - Nanotechnology Conference

Filling a Pipeline; One Company’s Perspective

Bruce M. Pratt

Bruce M. Pratt

Vice President
Science Development
Genzyme Corporation, USA

Dr. Bruce M. Pratt is Vice President, Science Development, for Genzyme Corporation, with responsibilities in the identification and evaluation of early stage opportunities (primarily therapeutic products) and proactive, selective outreach activities to the academic, biotechnology and life science venture capital sectors. He has worked for Genzyme for 17+ years in positions of increasing responsibility in Cell & Protein Therapeutics Research & Development, most recently as Sr. Director of Cell Biology. For 2+ years, through July 2004, he was based in one of Genzyme’s European offices, identifying early stage European research and product opportunities as well as developing relationships with biotechnology companies and academic centers of excellence.

Prior to his work at Genzyme, Dr. Pratt worked at Collagen Corporation and Celtrix Pharmaceuticals in Palo Alto California. He earned his Ph.D. from Michigan State University and was a post-doctoral fellow at Yale University School of Medicine, Department of Pathology.\n

View Confimed Speakers

Back to Conferences & Symposia

Nanotechnology Conference | Terms of use | Privacy policy | Contact | NSTI Home
Program | Technical Conferences | Business & Development | Nano Impact Workshop | Nanotech Job Fair | Expo |
Nanotech 2006 Home | Press Room | Venue | Subscribe | Site Map
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.